Abstract
MRI and morphological investigations into internal organ tissues and tumors in rats with liver cancer PC-1 under the intraperitoneal administration of magnetite hydrosols have been performed. The absence of any toxic effect of magnetite nanoparticles at low concentrations (0.325 mg/mL) has been determined using neutrophil granulocytes. A technique for the synthesis of citrate-stabilized magnetite hydrosols by the coprecipitation of Fe2+ and Fe3+ salts is described. Their electrokinetic potential is −32 ± 2 mV at pH 6.5 ± 0.1. The size distribution of magnetite nanoparticles is obtained by dynamic light scattering. The average size of magnetite nanoparticles is 23 ± 6 nm. The absorption spectra of magnetite hydrosols have been measured. The dependence of the optical density on the concentration has also been obtained. Molar absorption coefficients of magnetite nanoparticles have been calculated at the following wavelengths: 532, 633, 660, and 785 nm.
Similar content being viewed by others
References
R. Weissleder, A. Bogdanov, E. A. Neuwelt, and M. Papisov, “Longcirculating iron oxides for MR imaging,” Adv. Drug Deliv. Rev. 16, 321 (1995).
P. Reimer and R. Weissleder, “Development and experimental application of receptor-specific MR contrast media,” Radiologe 36, 153 (1996).
C. Chouly, D. Pouliquen, I. Lucet, J. J. Jeune, and P. Jallet, “Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution,” J. Microencapsulat. 13, 245 (1996).
E. Okon, D. Pouliquen, P. Okon, Z. V. Kovaleva, T. P. Stepanova, S. G. Lavit, B. N. Kudryavtsev, and P. Jallet, “Biodegradation of magnetite dextran manoparticles in the rat: a histologic and biophysical study,” Lab Invest. 71, 895 (1994).
C. W. Jung and P. Jacobs, “Physical and chemical properties of superparamagnetic iron-oxide MR contrast agents; ferumoxides, ferumoxtran, ferumoxsil,” Magn. Reson. Imaging 13, 661 (1995).
Y. Jun, J.-H. Lee, and J. Cheon, “Chemical design of nanoparticle probes for high-performance magnetic resonance imaging,” Angewandte Chem. Int. Ed. 47, 5122 (2008).
P. K. Gupta and C. T. Hung, “Magnetically controlled targeted microcarrier systems,” Life Sci. 44, 175 (1989).
A. S. Lubbe, C. Bergemann, W. Huhnt, T. Fricke, H. Riess, J. W. Brock, and D. Huhn, “Preclinical experiences with magnetic drug targeting: tolerance and efficacy,” Cancer Res. 56, 4694 (1996).
A. K. Gupta and A. S. G. Curtis, “Lactoferrin and ceruloplasmin derivatized superparamagneticiron oxide nanoparticles for targeting cell surface receptors,” Biomater. 25, 3029 (2004).
D. C. F. Chan, D. Kirpotin, and P. A. Bunn, “Synthesis and evaluation of colloidal magnetic iron-oxides for the site-specific radiofrequencyinduced hyperthermia of cancer,” J. Magn. Magn. Mater. 122, 374 (1993).
U. Häfeli, W. Schütt, J. Teller, and M. Zborowski, Scientific and Clinical Applications of Magnetic Carriers (Plenum Press, New York, 1997).
M. Levy, F. Lagarde, V.-A. Maraloiu, M.-G. Blanchin, F. Gendron, C. Wilhelm, and F. Gazeau, “Degradability of superparamagnetic nanoparticles in a model of intracellular environment: follow-up of magnetic, structural and chemical properties,” Nanotecnol. 21, 395103 (2010).
M. De, P. S. Ghosh, and V. M. Rotello, “Applications of nanoparticles in biology,” Adv. Mater. 20, 4225 (2008).
S. Laurent, D. Forge, M. Port, A. Roch, C. Robic, L. Vander Elst, and R. N. Muller, “Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications,” Chem. Rev. 108, 2064 (2008).
R. M. Cornell and U. Schertmann, Iron Oxides in the Laboratory; Preparation and Characterization (VCH, Weinheim, 1991).
F. A. Cotton and G. Wilkinson, in Advanced Inorganic Chemistry (Wiley Intersci., New York, 1988).
P. V. Kamat, Nanoscale Materials (Kluwer Acad. Publ., Boston, 2003).
D. K. Kim, Y. Zhang, W. Voit, K. V. Rao, and M. Muhammed, “Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles,” J. Magn. Magn. Mater. 225, 30 (2001).
Y. Zhang, N. Kohler, and M. Zhang, “Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake,” Biomater. 23, 1553 (2002).
E. Miller, N. A. Peppas, and D. N. Winslow, “Morphological changes of ethylene/vinyl acetate based on controlled delivery systems during release of water-soluble solutes,” J. Membr. Sci. 14, 79 (1983).
X. Zhao and J. M. Harris, “Novel degradable poly(ethylene glycol) hydrogels for controlled release of protein,” J. Pharm. Sci. 87, 1450 (1998).
J. M. Ruiz and J. P. Benoit, “In vivo peptide release from poly(lactic-coglycolic acid) copolymer 50/50 microspheres,” J. Cont. Rel. 16, 177 (1991).
J. K. Li, N. Wang, and X. E. Wu, “A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery,” J. Pharm. Sci. 86, 891 (1997).
K. Akiyoshi and J. Sunmoto, “Supramolecular assembly of hydrophobized polysaccharides,” Supramol. Sci. 3, 157 (1996).
H. G. Schwick and K. Heide, “Immunochemistry and immunology of collagen and gelatin,” Bibl. Haematol. 3, 111 (1969).
S. P. Massia, J. Stark, and D. S. Letbetter, “Surface immobilized dextran limits cell adhesion and spreading,” Biomater. 21, 2253 (2000).
J. Yu, C.-W. Lee, S.-S. Im, and J.-S. Lee, “Structure and magnetic properties of SiO2 coated Fe2O3 nanoparticles synthesized by chemical vapor condensation process,” Rev. Adv. Mater. Sci. 4, 55 (2003).
M. Chen, S. Yamamuro, D. Farrell, and S. A. Majetich, “Gold-coated iron nanoparticles for biomedical applications,” J. Appl. Phys. 93, 7551 (2003).
J. Lin, W. Zhou, A. Kumbhar, J. Fang, E. E. Carpenter, and C. J. O’Connor, “Gold-coated iron (Fe@Au) nanoparticles: synthesis, characterization, and magnetic field-induced self-assembly,” J. Solid State Chem. 159, 26 (2001).
A. K. Gupta, C. Berry, M. Gupta, and A. Curtis, “Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis,” IEEE Trans. Nanobiosci. 2, 256 (2003).
A. Moore, J. Basilion, E. A. Chiocca, and R. Weissleder, “Measuring transferrin receptor gene expression by NMR imaging,” Biochim. Biophys. Acta 1402, 239 (1998).
C. C. Berry, S. Charles, S. Wells, M. J. Dalby, and A. S. G. Curtis, “The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture,” Int. J. Pharm. 269, 211 (2004).
M. E. Baker, “Albumin’s role in steroid hormone action and the origins of vertebrates: is albumin an essential protein,” FEBS Lett. 439, 9 (1998).
A. M. Jubb and H. C. Allen, “Vibrational spectroscopic characterization of hematite, maghemite, and magnetite thin films produced by vapor deposition,” Appl. Mater. Interf. 10, 2804 (2010).
R. Weissleder, D. D. Stark, B. L. Engelstad, B. R. Bacon, C. C. Compton, D. L. White, P. Jacobs, and J. Lewis, “Superparamagnetic iron oxide: pharmacokinetics and toxicity,” Am. J. Roentgenol. 152, 167 (1989).
A. S. Lubbe, C. Alexiou, and C. Bergemann, “Clinical applications of magnetic drug targeting,” J. Surg. Res. 95, 200 (2001).
M. D. Kaminski and A. J. Rosengart, “Detoxification of blood using injectable magnetic nanoparticles: a conceptual technology description,” J. Magn. Magn. Mater. 293, 389 (2005).
A. B. Chin and I. I. Yaacob, “Synthesis and characterization of magnetic iron oxide nanoparticles via microemulsion and massart’s procedure,” J. Mater. Process Technol. 191, 235 (2007).
C. Albornoz and S. E. Jacobo, “Preparation of a biocompatible magnetic film from an aqueous ferrofluid,” J. Magn. Magn. Mater. 305, 12 (2006).
E. H. Kim, H. S. Lee, B. K. Kwak, and B. K. Kim, “Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent,” J. Magn. Magn. Mater. 289, 328 (2005).
J. Wan, X. Chen, Z. Wang, X. Yang, and Y. Qian, “A soft-template-assisted hydrothermal approach to single-crystal Fe3O4 nanorods,” J. Cryst. Growth 276, 571 (2005).
M. Kimata, D. Nakagawa, and M. Hasegawa, “Preparation of monodisperse magnetic particles by hydrolysis of iron alkoxide,” Powder Technol. 132, 112 (2003).
I. Martinez-Mera, M. E. Espinosa, R. Perez-Hernandez, and J. Arenas-Alatorre, “Synthesis of magnetite (Fe3O4) nanoparticles without surfactants at room temperature,” J. Mater. Lett. 61, 4447 (2007).
Y -K. Sun, M. Ma, Y. Zhang, and N. Gu, “Synthesis of nanometer-size maghemite particles from magnetite,” Colloids Surf. A: Physicochem. Eng. Asp. 245, 15 (2004).
S.-J. Lee, J.-R. Jeong, S.-C. Shin, J.-C. Kim, and J. Kim, “Synthesis and characterization of superparamagnetic maghemite nanoparticles prepared by coprecipitation technique,” J. Magn. Magn. Mater. 282, 147 (2004).
R. Massart, “Preparation of aqueous magnetic liquids in alkaline and acidic media,” IEEE Trans. Magn. 17, 1247 (1981).
S.V. German, O.A. Inozemtseva, A.V. Markin, Kh. Metvalli, G.B. Khomutov, D.A. Gorin, “Synthesis of magnetite hydrosols in inert atmosphere”, Colloid Journal 75, No. 4, 483 (2013).
I. Dincer, O. Tozkoparan, S. V. German, A. V. Markin, O. Yildirim, G. B. Khomutov, D. A. Gorin, S. B. Venig, and Y. Elerman, “Effect of the number of iron oxide nanoparticle layers on the magnetic properties of nanocomposite LbL assemblies,” J. Magn. Magn. Mater. 324, 2958 (2012).
Guide for Preclinical Tests of Medicinal Agents, Ed. by A. N. Mironov (Grif i K, Moscow, 2012), Part 1 [in Russian].
I. V. Podosinnikov, L. G. Nilova, and I. V. Babichenko, “The way to determine chemotactic activity for white blood cells,” Lab. Delo, No. 8, 68 (1981).
N. Khlebtsov and L. Dykman, “Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies,” Chem. Soc. Rev. 40, 1647 (2011).
Yu. S. Tarakhovskii, Intelligent Lipidic Nanocontainers for Addressed Delivery of Pharmaceutical Substances (Izd. LKI, Moscow, 2011) [in Russian].
L. N. Donselaar and A. P. Philipse, “Interactions between Silica colloids with magnetite cores: diffusion, sedimentation and light scattering,” J. Colloid Interface Sci. 212, 14 (1999).
A. K. Gupta and M. Gupta, “Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles,” Biomater. 26, 1565 (2005).
S. N. Pleskova, E. N. Gorshkova, E. R. Mikheeva, and A. N. Shushunov, “The way to investigate biocompatibility between nanoparticles and fluorescence center of Er/Yb in neutrophilous granulocytes,” Tsitologiya 53(5), 444 (2011).
N. M. Anichkov and M. A. Pal’tsev, Pathoanatomy (Meditsina, Moscow, 2001) [in Russian].
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © S.V. German, O.A. Inozemtseva, N.A. Navolokin, E.E. Pudovkina, V.V. Zuev, E.K. Volkova, A.B. Bucharskaya, S.N. Pleskova, G.N. Maslyakova, D.A. Gorin, 2013, published in Rossiiskie Nanotekhnologii, 2013, Vol. 8, Nos. 7–8.
Rights and permissions
About this article
Cite this article
German, S.V., Inozemtseva, O.A., Navolokin, N.A. et al. Synthesis of magnetite hydrosols and assessment of their impact on living systems at the cellular and tissue levels using MRI and morphological investigation. Nanotechnol Russia 8, 573–580 (2013). https://doi.org/10.1134/S1995078013040034
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1995078013040034